Monday 22 June 2026
FTSE 100 10,437.85 +0.07%FTSE 250 23,197.01 -0.71%UK FTSE All Share 5,611.44 -0.02%FTSE Small Cap 7,894.35 -0.40%FTSE AIM All-Share Index 794.27 -1.37%Microsoft 367.34 -5.99%NVIDIA 208.65 +1.69%Apple 297.01 +2.02%Tesla 405.05 -0.34%Amazon 232.79 -2.41%Google 348.78 -2.62%S&P 500 7,472.79 +0.56%Nasdaq 26,166.60 +1.07%Dow 51,712.71 +1.00%Russell 2000 3,004.40 +2.05%CBOE Volatility Index 17.28 +5.30%US 10Y Treasury 4.51% +1.83%US 30Y Treasury 4.95% +0.39%US 5Y Treasury 4.29% +3.28%US 13w Treasury 3.68% +1.38%Euro Stoxx 50 6,311.32 +0.86%DAX 25,139.69 +0.99%CAC 40 8,400.11 -0.56%AEX-Index 1,082.93 +1.20%IBEX 35 19,542.30 +1.98%Nikkei 225 72,353.96 +4.25%Hang Seng 23,768.52 -3.84%SSE Composite Index 4,163.10 +1.63%Taiwan Weighted 47,741.51 +5.16%KOSPI Composite Index 9,114.55 +6.65%Gold $4,210.20 -2.79%Silver $65.24 -6.67%Brent Crude Oil $77.99 -1.23%Natural Gas $3.27 +0.96%Copper $6.37 -1.87%Dollar Index 101.01 +1.48%GBP/USD 1.3251 -1.23%GBP/EUR 1.1587 +0.12%GBP/AUD 1.8911 -0.30%EUR/USD 1.1434 -1.38%Bitcoin (USD) $64,386 +2.37%Ethereum (USD) $1,734 +1.40%XRP (USD) $1.1311 -1.25%Solana (USD) $72.75 +4.49%TRON (USD) $0.3326 +3.81%FTSE 100 10,437.85 +0.07%FTSE 250 23,197.01 -0.71%UK FTSE All Share 5,611.44 -0.02%FTSE Small Cap 7,894.35 -0.40%FTSE AIM All-Share Index 794.27 -1.37%Microsoft 367.34 -5.99%NVIDIA 208.65 +1.69%Apple 297.01 +2.02%Tesla 405.05 -0.34%Amazon 232.79 -2.41%Google 348.78 -2.62%S&P 500 7,472.79 +0.56%Nasdaq 26,166.60 +1.07%Dow 51,712.71 +1.00%Russell 2000 3,004.40 +2.05%CBOE Volatility Index 17.28 +5.30%US 10Y Treasury 4.51% +1.83%US 30Y Treasury 4.95% +0.39%US 5Y Treasury 4.29% +3.28%US 13w Treasury 3.68% +1.38%Euro Stoxx 50 6,311.32 +0.86%DAX 25,139.69 +0.99%CAC 40 8,400.11 -0.56%AEX-Index 1,082.93 +1.20%IBEX 35 19,542.30 +1.98%Nikkei 225 72,353.96 +4.25%Hang Seng 23,768.52 -3.84%SSE Composite Index 4,163.10 +1.63%Taiwan Weighted 47,741.51 +5.16%KOSPI Composite Index 9,114.55 +6.65%Gold $4,210.20 -2.79%Silver $65.24 -6.67%Brent Crude Oil $77.99 -1.23%Natural Gas $3.27 +0.96%Copper $6.37 -1.87%Dollar Index 101.01 +1.48%GBP/USD 1.3251 -1.23%GBP/EUR 1.1587 +0.12%GBP/AUD 1.8911 -0.30%EUR/USD 1.1434 -1.38%Bitcoin (USD) $64,386 +2.37%Ethereum (USD) $1,734 +1.40%XRP (USD) $1.1311 -1.25%Solana (USD) $72.75 +4.49%TRON (USD) $0.3326 +3.81%
Advertisement
Follow News in 60 on Facebook
UK Weather
London 24°C Light rain showerBirmingham 25°C SunnyManchester 22°C Light rain showerNewcastle 22°C SunnyBristol 24°C SunnyCardiff 23°C SunnyEdinburgh 18°C CloudyBelfast 17°C Mist

Contempt Ruling Highlights Tensions Over Ebola Facility in Kenya

Advertisement
Follow News in 60 on Facebook

A Kenyan court has found Health Minister Aden Duale in contempt for ignoring orders to halt construction of a quarantine facility for US nationals potentially exposed to Ebola. This facility, located at Laikipia Air Base, has sparked significant public outcry, with citizens fearing the importation of the virus into a country that has reported no infections.

The court’s ruling underscores the growing tensions between the government and the public, particularly as the Health Minister continues to assert that the project will proceed despite legal setbacks. Critics argue that the facility’s development lacked transparency and public consultation, raising concerns about health and safety protocols.

The situation reflects broader issues within Kenya’s healthcare system, which is already under strain. Medical professionals have voiced their worries that the facility could exacerbate existing vulnerabilities, especially given the recent Ebola outbreak in neighbouring countries.

As the court prepares to impose sanctions on Duale, the implications of this case extend beyond legal ramifications, potentially affecting public trust in government health initiatives and international partnerships. The outcome may influence how future health agreements are approached in Kenya, particularly those involving foreign nations.

Source: Al Jazeera

Read more Health news →

News Category: Health Tags: court, ebola, government, health, kenya

Leave a comment

Your email address will not be published. Required fields are marked *